NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4*4 million participants. Lancet, 2016; 387: 1513–30.
2.
Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. GrunbergerG, BaileyTS, CohenAJ, FloodTM, HandelsmanY, HellmanR, JovanovičL, MoghissiES, OrzeckEA; AACE Insulin Pump Management Task Force. Endocr Pract, 2010; 16: 746–62.
3.
SzypowskaA, SchwandtA, SvenssonJ, et al.; SWEET Study Group. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry. Pediatr Diabetes, 2016; Suppl 23: 38–45.
4.
NeylonOM, SkinnerTC, O'ConnellMA, CameronFJ. A novel tool to predict youth who will show recommended usage of diabetes technologies. Pediatr Diabetes, 2016; 17: 174–83.
5.
SilversteinJ, KlingensmithG, CopelandK, PlotnickL, KaufmanF, LaffelL, DeebL, GreyM, AndersonB, HolzmeisterLA, ClarkN; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care, 2005; 28: 186–212.
6.
OrisL, RassartJ, PrikkenS, VerschuerenM, GoubertL, MoonsP, BergCA, WeetsI, LuyckxK. Illness identity in adolescents and emerging adults With type 1 diabetes: Introducing the illness identity questionnaire. Diabetes Care, 2016; 39: 757–63.
7.
PolonskyWH, FisherL, HesslerD, EdelmanSV. Development of a new measure for assessing glucose monitoring device-related treatment satisfaction and quality of life. Diabetes Technol Ther, 2015; 17: 657–63.
8.
PolonskyWH, FisherL, HesslerD, EdelmanSV. Development of a new measure for assessing insulin delivery device satisfaction in patients with type 1 and type 2 diabetes. Diabetes Technol Ther, 2015; 17: 773–79.
9.
What quality of life? The WHOQOL Group. World Health Organization Quality of Life Assessment. World Health Forum, 1996; 17: 354–6.
10.
Snell-BergeonJK. Assessing insulin delivery device satisfaction in patients with type 1 and type 2 diabetes. Diabetes Technol Ther, 2015; 17(11): 759–62.
11.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Washington, D.C: American Psychiatric Association.
12.
GrunbergerG, AbelsethJM, BaileyTS, BodeBW, HandelsmanY, HellmanR, JovanovičL, LaneWS, RaskinP, TamborlaneWV, RothermelC. Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology Insulin Pump Management Task Force. Endocr Pract, 2014; 20: 463–89.
13.
PrinzN, BächleC, BeckerM, BergerG, GallerA, HaberlandH, MeusersM, MirzaJ, PlenerPL, von SengbuschS, ThieneltM, HollRW. on behalf of the DPV Initiative. Insulin pumps in type 1 diabetes with mental disorders: Real-life clinical data indicate discrepancies to recommendations. Diabetes Technol Ther, 2016; 18: 34–8.
14.
WittchenHU, JacobiF, RehmJ, GustavssonA, SvenssonM, JönssonB, OlesenJ, AllgulanderC, AlonsoJ, FaravelliC, FratiglioniL, JennumP, LiebR, MaerckerA, van OsJ, PreisigM, Salvador-CarullaL, SimonR, SteinhausenHC. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol, 2011; 21: 655–79.
15.
RaiffBR, BarrryVB, RidenourTA, JitnarinN. Internet-based incentives increase blood glucose testing with a non-adherent, diverse sample of teens with type 1 diabetes mellitus: a randomized controlled Trial. Transl Behav Med, 2016; 6: 179–88.
16.
ArnaudN, BaldusC, ElgánTH, De PaepeN, TønnesenH, CsémyL, ThomasiusR. Effectiveness of a web-based screening and fully automated brief motivational intervention for adolescent substance use: A randomized controlled trial. J Med Internet Res, 2016; 18: e103.
17.
PhillipM, BattelinoT, RodriguezH, DanneT, KaufmanF; European Society for Paediatric Endocrinology; Lawson Wilkins Pediatric Endocrine Society; International Society for Pediatric and Adolescent Diabetes; American Diabetes Association; European Association for the Study of Diabetes. Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 2007; 30: 1653–62.
18.
PhillipM, DanneT, ShalitinS, BuckinghamB, LaffelL, TamborlaneW, BattelinoT; Consensus Forum Participants. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes, 2012; 13: 215–28.
19.
Drobnic̆ RadobuljacM, Shmueli-GoetzY. Attachment to caregivers and type 1 diabetes in children. Zdrav Var, 2015; 54: 126–30.
20.
StangerC, RyanSR, DelheyLM, ThrailkillK, LiZ, LiZ, BudneyAJ. A multicomponent motivational intervention to improve adherence among adolescents with poorly controlled type 1 diabetes: a pilot study. J Pediatr Psychol, 2013; 38: 629–37.
21.
PateT, RutarM, BattelinoT, Drobnič RadobuljacM, BratinaN. Support group for parents coping with children with type 1 diabetes. Zdrav Var, 2015; 54: 79–85.
